Fragrance composition with lasting fragrance expression

Abstract

The invention relates to a fragrance composition, in particular to a fragrance composition with lasting fragrance trace expression. The invention also relates to the use of the fragrance composition and to a perfumed consumer product containing the fragrance composition.

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to U.S. Provisional Application No. 63 / 354,535 filed on June 22, 2022 and European Application No. 22187312.8 filed on July 27, 2022. The entire contents of these applications are expressly incorporated herein by this reference. Technical Field

[0003] The present invention relates to a fragrance composition, in particular a fragrance composition having a long-lasting fragrance trail, and also relates to the use of the fragrance composition and a scented consumer product containing the fragrance composition. Background Art

[0004] Fragrance performance, especially in the context of fine fragrance, can be divided into three main attributes: impact (the initial effect), long-lastingness, and projection (the extent of the spread), the latter of which includes "diffusion" and scent trace characteristics. Projection (sometimes also called "volume" in the art) describes the degree to which the fragrance is perceived by others at a distance.

[0005] The term "diffusion" in the perfumery industry generally refers to the degree to which a fragrance (or aromatic ingredient) is perceived in the "aura" or vicinity of the fragrance source (the person who applies the fragrance). Aura in this context is defined as the space surrounding the fragrance source, where diffusion from the vapor-liquid interface (i.e. liquid perfume on the skin exposed to air) is a relevant fragrance transport mechanism. Such a definition also exists in the following publication: 'A Novel Technology to Study the Emission of Fragrance from the Skin', by Braja D. Mookherjee, Subha M. Patel, Robert W. Trenkle and Richard A. Wilson, published in Cosmetics & Toiletries (1998), 113(7), 53-56, 58-60.

[0006] Unlike ambience, scent trails are associated with noticeable movement and air convection. This can be the movement of the person applying the fragrance (walking), the movement of the air around the person (wind or ventilation), or both (a person walking down the street, exposed to natural air currents). Movement causes a certain amount of air convection, which carries the fragrance away from the source of the fragrance (the person applying the fragrance) and makes it smellable to others. The scent trail performance of a high-quality fragrance is usually judged by the maximum distance from the fragrance source at which the fragrance is at least perceptible and preferably recognizable to others. It is worth noting that whenever there is a significant gas phase concentration gradient, such as odorless ambient air, the degree of dilution of the fragrance in the air is closely related to the distance from the fragrance source being evaluated.

[0007] While fragrance footprint is often mentioned in patent literature and scientific publications, there is still a gap in the published literature regarding the connection between long-range performance and the fragrance ingredients or fragrance blends that cause this performance, including their olfactory dose-response characteristics. The selection of materials and methods to improve the performance of fragrance footprint is often necessary. In many high-quality fragrance markets, scent footprint is a key consumer requirement and often a must-have. Therefore, scent footprint performance is becoming an integral part of fragrance success.

[0008] Therefore, there is a constant need for fragrance compositions that can provide the desired long-lasting fragrance performance. Summary of the invention

[0009] The following aspects of the present disclosure are directed to addressing one or more of the above-mentioned problems.

[0010] In a first aspect, the present disclosure relates to a fragrance composition comprising at least 4%, typically at least 5%, more typically at least 6% by weight of at least two Group A components relative to the total weight of the composition, wherein the Group A components are as described herein, and wherein the volatility of each of the at least two Group A components is less than 100 μg / L, typically 100 μg / L to 10 μg / L, or 10 μg / L to 0.001 μg / L.

[0011] In a second aspect, the present disclosure relates to a perfumed consumer product comprising the fragrance composition described herein.

[0012] In a third aspect, the present disclosure relates to the use of a fragrance composition or a perfumed consumer product as described herein for providing a long-lasting fragrance trace. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 The trace intensity of the comparative composition and the composition according to the present disclosure at 1 meter, 2 meters and 3 meters after 30 minutes of drydown is shown.

[0014] Figure 2 The scent trace intensity of the comparative composition and the composition according to the present disclosure at 1 meter, 2 meters and 3 meters after 4 hours of volatilization is shown.

[0015] Figure 3 The scent trace intensity of the comparative composition and the composition according to the present disclosure at 1 meter and 3 meters after 30 minutes of volatilization is shown.

[0016] Figure 4 The scent trace intensity of the comparative composition and the composition according to the present disclosure at 1 meter and 3 meters after 4 hours of volatilization is shown.

[0017] Figure 5 The scent trace intensity of a floral fragrance chassis, an inventive product according to the present disclosure, and a commercial product at 1 meter and 3 meters after 2 hours of volatilization is shown. DETAILED DESCRIPTION

[0018] As used herein, the terms "a", "an" or "the" mean "one or more" or "at least one", unless otherwise specified.

[0019] Although compositions and methods are described in terms of "comprising," "containing," or "including" various components or steps, compositions and methods may also "consist essentially of" or "consist of" the various components, materials, and steps. As used herein, the term "consist essentially of" should be interpreted as including the listed components, materials, or steps and such additional components, materials, or steps that do not materially affect the basic and novel properties of the composition or method. In some embodiments, a composition "consisting essentially of" according to an embodiment of the present disclosure does not include any additional components or materials that change the basic and novel properties of the composition.

[0020] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this specification belongs.

[0021] It should be understood that any numerical range described herein is intended to include all subranges contained therein. For example, a range of "1 to 10" is intended to include all subranges between the stated minimum value of 1 and the stated maximum value of 10; that is, having a minimum value equal to or greater than 1 and a maximum value equal to or less than 10. Since the disclosed numerical ranges are continuous, they include every value between the minimum and maximum values. Unless otherwise expressly stated, the various numerical ranges specified in this application are approximate.

[0022] As used herein, unless otherwise indicated, the term "about" or "approximately" refers to the acceptable error of a particular value determined by one skilled in the art, which depends in part on how the value is measured or determined. In certain embodiments, the term "about" or "approximately" refers to within 1, 2, 3, or 4 standard deviations. In certain embodiments, the term "about" or "approximately" refers to within 50%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, or 0.05% of a given value or range.

[0023] Throughout this disclosure, various publications may be incorporated by reference. If the meaning of any term in these publications incorporated by reference conflicts with the meaning of the term in this disclosure, the meaning of the term in this disclosure takes precedence unless otherwise stated.

[0024] In the overall content of the present disclosure, various chemical names and structures can be listed. Unless otherwise stated, any stereoisomers of the listed chemical names or structures are considered, such as enantiomers, diastereomers, anomers, epimers, etc.; and geometric isomers, such as cis / trans or E / Z isomers. It will be understood by those of ordinary skill in the art that stereoisomers can have a stereocenter, thereby producing enantiomers, or have multiple stereocenters, thereby producing diastereomers, each stereocenter having one of two different stereochemicals (i.e., R or S). Enantiomers are characterized in that they can rotate the oncoming plane polarized light to the right, referred to as right-handed, "(+)" or "D", or rotate to the left, referred to as left-handed, "(-)" or "L". Enantiomers can exist as racemic mixtures or non-racemic (scalemic, ratio optical rotation) mixtures. Geometric isomers refer to isomers that differ in the spatial relationship of atoms around a double bond and are usually designated as E or Z as commonly understood in the chemical art. Geometric isomers may also exist as a mixture of E and Z isomers. All such isomeric variations of the chemical names or structures described herein are included.

[0025] In a first aspect, the present disclosure relates to a fragrance composition comprising at least 4%, typically at least 5%, more typically at least 6% by weight of at least two Group A components relative to the total weight of the composition, wherein the Group A components are as described herein, and wherein the volatility of each of the at least two Group A components is less than 100 μg / L, typically 100 μg / L to 10 μg / L, or 10 μg / L to 0.001 μg / L.

[0026] It has been discovered that certain fragrance ingredients are capable of providing high levels of long-lasting scent performance when used in fragrance compositions. As used herein, fragrance ingredients that provide high levels of long-lasting scent performance are classified as Group A ingredients. In addition to being able to provide high levels of long-lasting scent performance, Group A ingredients can also be characterized by a volatility of less than 100 μg / L. Although Group A ingredients can be characterized by volatility, it should be noted that volatility has no connection to the ability of an ingredient to provide high levels of long-lasting scent performance. Therefore, the volatility of an ingredient is not indicative of the ability of the ingredient to provide high levels of long-lasting scent performance.

[0027] The components of Group A having a volatility of less than 100 μg / L are selected from the group consisting of:

[0028] (3aRS,5aRS,8aRS,8bSR)-2,2,6,6,7,8,8-heptamethyldecahydro-2H-indeno[4,5-b]furan,

[0029] 4-Methoxybenzaldehyde,

[0030] (+-)-1-(5-propyl-1,3-benzodioxol-2-yl) ketene,

[0031] 3-(4-tert-Butylphenyl)propanal,

[0032] 3-Butylidene-1-benzo[C]furanone,

[0033] 7-methyl-2H-1,5-benzodioxepin-3(4H)-one,

[0034] 5-isopropyl-2-methylphenol,

[0035] 7-isopropyl-2H,4H-1,5-benzodioxepin-3-one,

[0036] 4,8-cyclododecadien-1-one,

[0037] (E)-3-phenyl-2-acrylonitrile,

[0038] 3-Methyl-5-phenyl-2-pentenenitrile,

[0039] (3S,3aR,5R,8S,8aS)-5-isopropenyl-3,8-dimethyloctahydro-3a(1H)-azulenol,

[0040] Isopropenyl-1,4-dimethyldecahydro-4-azulenol,

[0041] (1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane-3-ol,

[0042] (1R,3R,6S,7S,8S)-3-ethoxy-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane,

[0043] (+-)-6-methyl-7-oxa-1-thia-4-azaspiro[4.4]nonane,

[0044] 4-Methylphenyl 3-methylbutyrate,

[0045] (2E)-1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one,

[0046] (+-)-(2E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one,

[0047] (2E)-2-Dodecenal,

[0048] (+-)-4-Methylene-2-phenyltetrahydro-2H-pyran,

[0049] (+-)-4-methyl-6-phenyl-3,6-dihydro-2H-pyran,

[0050] (+-)-4-methyl-2-phenyl-3,6-dihydro-2H-pyran,

[0051] (E)-3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, 2,3-epoxy-3-phenylbutyric acid ethyl ester,

[0052] 2-ethyl-3-hydroxy-4(4H)-pyrone,

[0053] 2-Methoxy-4-(2-propen-1-yl)phenol, 4-allyl-2-methoxyphenyl acetate,

[0054] 2-methyl-4-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-1-ol,

[0055] (+-)-5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone,

[0056] (+-)-2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone,

[0057] 4-methylphenoxy)acetaldehyde,

[0058] 2-methoxy-4-[(1E)-1-propen-1-yl]phenol,

[0059] 8-Isopropylquinoline,

[0060] 6-Isopropylquinoline,

[0061] 3,7-Dimethyl-6-octen-1-ol,

[0062] 3,7-Dimethyl-7-octen-1-ol,

[0063] (+-)-2-methyl-3-[4-(2-methyl-2-propyl)phenyl]propanal,

[0064] (+-)-2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxane, 3,12-tridecadienenitrile,

[0065] 2-aminobenzoic acid methyl ester,

[0066] 2,6-Dimethoxyphenol,

[0067] 3,6-Dimethylhexahydro-1-benzofuran-2(3H)-one,

[0068] 1-(5,5-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one,

[0069] (+-)-1-(5-ethyl-5-methyl-1-cyclohexen-1-yl)-4-penten-1-one, 1-(3-methyl-1-benzofuran-2-yl)ethanone,

[0070] 5-Nonanolactone,

[0071] (+-)-4-nonalactone,

[0072] Perhydro-2-benzopyrone,

[0073] 1-(2-aminophenyl)-1-ethanone,

[0074] (-)-(1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane-3-ol, (E)-2-ethoxy-5-(1-propenyl)phenol,

[0075] 3-Methylindole,

[0076] 1-Oxaspiro[4.5]decan-2-one,

[0077] (4Z)-4-Dodecenal,

[0078] 1,5,9-Trimethyl-4,8-decadienyl acetate,

[0079] 3-Methyl-4-octanolactone,

[0080] 3-Propylphenol,

[0081] 2-Methoxynaphthalene,

[0082] Indole,

[0083] 5-ethyl-3-hydroxy-4-methyl-2(5H)-furanone,

[0084] (+-)-2-[4-(2-hydroxy-2-methylpropyl)phenyl]propanal,

[0085] 3-(3-(2-hydroxy-2-methylpropyl)phenyl)propanal,

[0086] 3-[4-(2-Hydroxy-2-methylpropyl)phenyl]propanal,

[0087] 4-(4-methoxyphenyl)-2-butanone,

[0088] 2-(3-phenylpropyl)pyridine,

[0089] (-)-(2E)-2-ethyl-4-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-2-buten-1-ol,

[0090] (+-)-6-pentyltetrahydro-2H-pyran-2-one,

[0091] 3-(3,3-Dimethyl-2,3-dihydro-1H-inden-5-yl)propanal

[0092] 3-(1,1-Dimethyl-2,3-dihydro-1H-inden-4-yl)propanal

[0093] 3-(1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal,

[0094] (E)-2-methoxy-4-(1-propenyl)phenyl acetate,

[0095] (1'S,3'R)-{1-methyl-2-[(1',2',2'-trimethylbicyclo[3.1.0]hex-3'-yl)methyl]cyclopropyl}methanol,

[0096] (+-)-(2,5-dimethyl-2,3-dihydro-1H-inden-2-yl)methanol,

[0097] (+-)-3-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde,

[0098] (+-)-4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde,

[0099] 2,4-dihydroxy-3,6-dimethylbenzoic acid methyl ester,

[0100] 4-(4-Hydroxyphenyl)-2-butanone,

[0101] (+)-(1R,7R)-10,10-dimethyl-tricyclo[7.1.1.0(2,7)]undec-2-en-4-one,

[0102] (+-)-5-heptyldihydro-2(3H)-furanone,

[0103] 4-Hydroxy-3-methoxybenzaldehyde,

[0104] (-)-(3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan,

[0105] (-)-(1R,3S,7R,8R,10S,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.0(1,10).0(3,7)]tetradecane,

[0106] 3-ethoxy-4-hydroxybenzaldehyde, and any combination thereof.

[0107] The volatility of the Group A components described herein may be from 100 μg / L to 10 μg / L, or from 10 μg / L to 0.001 μg / L.

[0108] The Group A components described herein having a volatility of 100 μg / L to 10 μg / L are selected from the group consisting of:

[0109] (3aRS,5aRS,8aRS,8bSR)-2,2,6,6,7,8,8-heptamethyldecahydro-2H-indeno[4,5-b]furan,

[0110] 4-Methoxybenzaldehyde,

[0111] (+-)-1-(5-propyl-1,3-benzodioxol-2-yl) ketene,

[0112] 3-(4-tert-Butylphenyl)propanal,

[0113] 3-Butylidene-1-benzo[C]furanone,

[0114] 7-methyl-2H-1,5-benzodioxepin-3(4H)-one,

[0115] 5-isopropyl-2-methylphenol,

[0116] 7-isopropyl-2H,4H-1,5-benzodioxepin-3-one,

[0117] 4,8-cyclododecadien-1-one,

[0118] (E)-3-phenyl-2-acrylonitrile,

[0119] 3-Methyl-5-phenyl-2-pentenenitrile,

[0120] (3S,3aR,5R,8S,8aS)-5-isopropenyl-3,8-dimethyloctahydro-3a(1H)-azulenol,

[0121] Isopropenyl-1,4-dimethyldecahydro-4-azulenol,

[0122] (1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane-3-ol,

[0123] (1R,3R,6S,7S,8S)-3-ethoxy-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane,

[0124] (+-)-6-methyl-7-oxa-1-thia-4-azaspiro[4.4]nonane,

[0125] 4-Methylphenyl 3-methylbutyrate,

[0126] (2E)-1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one,

[0127] (+-)-(2E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one,

[0128] (2E)-2-Dodecenal,

[0129] (+-)-4-Methylene-2-phenyltetrahydro-2H-pyran,

[0130] (+-)-4-methyl-6-phenyl-3,6-dihydro-2H-pyran,

[0131] (+-)-4-methyl-2-phenyl-3,6-dihydro-2H-pyran,

[0132] (E)-3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, 2,3-epoxy-3-phenylbutyric acid ethyl ester,

[0133] 2-ethyl-3-hydroxy-4(4H)-pyrone,

[0134] 2-Methoxy-4-(2-propen-1-yl)phenol, 4-allyl-2-methoxyphenyl acetate,

[0135] 2-methyl-4-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-1-ol,

[0136] (+-)-5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone,

[0137] (+-)-2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone,

[0138] 4-methylphenoxy)acetaldehyde,

[0139] 2-methoxy-4-[(1E)-1-propen-1-yl]phenol,

[0140] 8-Isopropylquinoline,

[0141] 6-Isopropylquinoline,

[0142] 3,7-Dimethyl-6-octen-1-ol,

[0143] 3,7-Dimethyl-7-octen-1-ol,

[0144] (+-)-2-methyl-3-[4-(2-methyl-2-propyl)phenyl]propanal,

[0145] (+-)-2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxane, 3,12-tridecadienenitrile,

[0146] 2-aminobenzoic acid methyl ester,

[0147] 2,6-Dimethoxyphenol,

[0148] 3,6-Dimethylhexahydro-1-benzofuran-2(3H)-one,

[0149] 1-(5,5-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one,

[0150] (+-)-1-(5-ethyl-5-methyl-1-cyclohexen-1-yl)-4-penten-1-one, 1-(3-methyl-1-benzofuran-2-yl)ethanone,

[0151] 5-Nonanolactone,

[0152] (+-)-4-nonalactone,

[0153] Perhydro-2-benzopyrone,

[0154] 1-(2-aminophenyl)-1-ethanone,

[0155] (-)-(1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane-3-ol,

[0156] (E)-2-ethoxy-5-(1-propenyl)phenol,

[0157] 3-Methylindole,

[0158] 1-Oxaspiro[4.5]decan-2-one,

[0159] (4Z)-4-Dodecenal,

[0160] 1,5,9-Trimethyl-4,8-decadienyl acetate,

[0161] 3-Methyl-4-octanolactone,

[0162] 3-Propylphenol,

[0163] 2-Methoxynaphthalene,

[0164] Indole,

[0165] 5-ethyl-3-hydroxy-4-methyl-2(5H)-furanone, and combinations thereof.

[0166] The Group A components described herein having a volatility of 10 μg / L to 0.001 μg / L are selected from the group consisting of:

[0167] (+-)-2-[4-(2-hydroxy-2-methylpropyl)phenyl]propanal,

[0168] 3-(3-(2-hydroxy-2-methylpropyl)phenyl)propanal,

[0169] 3-[4-(2-Hydroxy-2-methylpropyl)phenyl]propanal,

[0170] 4-(4-methoxyphenyl)-2-butanone,

[0171] 2-(3-phenylpropyl)pyridine,

[0172] (-)-(2E)-2-ethyl-4-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-2-buten-1-ol,

[0173] (+-)-6-pentyltetrahydro-2H-pyran-2-one,

[0174] 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal,

[0175] 3-(1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)propanal,

[0176] 3-(1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal,

[0177] (E)-2-methoxy-4-(1-propenyl)phenyl acetate,

[0178] (1'S,3'R)-{1-methyl-2-[(1',2',2'-trimethylbicyclo[3.1.0]hex-3'-yl)methyl]cyclopropyl}methanol,

[0179] (+-)-(2,5-dimethyl-2,3-dihydro-1H-inden-2-yl)methanol;

[0180] (+-)-3-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde,

[0181] (+-)-4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde,

[0182] 2,4-dihydroxy-3,6-dimethylbenzoic acid methyl ester,

[0183] 4-(4-Hydroxyphenyl)-2-butanone,

[0184] (+)-(1R,7R)-10,10-dimethyl-tricyclo[7.1.1.0(2,7)]undec-2-en-4-one,

[0185] (+-)-5-heptyldihydro-2(3H)-furanone,

[0186] 4-Hydroxy-3-methoxybenzaldehyde,

[0187] (-)-(3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan,

[0188] (-)-(1R,3S,7R,8R,10S,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.0(1,10).0(3,7)]tetradecane,

[0189] 3-ethoxy-4-hydroxybenzaldehyde, and any combination thereof.

[0190] The fragrance composition comprises at least 4%, typically at least 5%, more typically at least 6% by weight of at least two Group A components relative to the total weight of the composition. In one embodiment, the at least two Group A components are present in an amount of 4% to 95%, typically 5% to 80%, more typically 6% to 70% by weight relative to the total weight of the composition.

[0191] The fragrance composition according to the present invention may also comprise at least 1% by weight, typically at least 3% by weight, more typically at least 4% by weight of at least two Group B components relative to the total weight of the composition, wherein the volatility of each of the at least two Group B components is less than 100 μg / L, typically 100 μg / L to 10 μg / L, or 10 μg / L to 0.001 μg / L.

[0192] The B group components described herein are such fragrance ingredients that, when used in a fragrance composition, can provide an ideal long-lasting scent performance. In addition to being able to provide an ideal long-lasting scent performance, the B group components can also have a volatility characteristic of less than 100 μg / L. Like the A group components, although the B group components may have a volatility characteristic, it should be noted that volatility has nothing to do with the ability of the ingredient to provide an ideal long-lasting scent performance. Therefore, the volatility of the B group components does not indicate the ability of the ingredient to provide an ideal long-lasting scent performance.

[0193] The Group B components having a volatility of less than 100 μg / L are selected from the group consisting of:

[0194] 1-(4-methoxyphenyl)-1-ethanone,

[0195] (+-)-8α,8A-Epoxy-perhydro-2β,5,5-trimethyl-2-trans-naphthol,

[0196] (+-)-4A,8A-Epoxy-perhydro-2,5,5-trimethyl-2-naphthol,

[0197] (+-)-4-(C-2,3-epoxy-2,6,6-trimethyl-R-1-cyclohexyl)-2-butanone,

[0198] 4-Methoxybenzyl acetate,

[0199] 4-Methoxy-1-benzyl alcohol,

[0200] (E)-2-Methyl-2-butenoic acid benzyl ester,

[0201] (+-)-1,1,2,3,3-pentamethyl-1,2,3,5,6,7-hexahydro-4H-inden-4-one,

[0202] Cedre-8-ene,

[0203] 1-(Cedre-8-en-9-yl)vinyl ketone,

[0204] (2E)-3-phenyl-2-propen-1-ol,

[0205] (E)-3-phenyl-2-propenal,

[0206] (E)-3-phenyl-2-propenyl acetate,

[0207] 3-methyl-2-[(2Z)-2-penten-1-yl]-2-cyclopenten-1-one,

[0208] 3-Hydroxy-2-methyl-4H-pyran-4-one,

[0209] Allyl (cyclohexyloxy)acetate,

[0210] 2-Methoxy-4-propylphenol,

[0211] 4-Methyl-2-phenyltetrahydro-2H-pyran,

[0212] (2E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one,

[0213] (E)-3-phenyl-2-propenoic acid ethyl ester,

[0214] 3-(4-ethylphenyl)-2,2-dimethylpropanal,

[0215] 3-(2-ethylphenyl)-2,2-dimethylpropanal,

[0216] (+-)-3-(3-isopropyl-1-phenyl)butyraldehyde,

[0217] (+-)-(E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one,

[0218] (+-)-(E)-1-(2,2-dimethyl-6-methylene-1-cyclohexyl)-1-penten-3-one,

[0219] (E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1-penten-3-one,

[0220] (E)-3,7-dimethyl-2,6-octadien-1-ol,

[0221] Benzo[d][1,3]dioxole-5-carboxaldehyde,

[0222] (+-)-(3E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (+-)-(1E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one,

[0223] (+-)-(E)-trans-α-irone,

[0224] (+-)-(E)-cis-α-irone,

[0225] (+-)-(E)-β-irone,

[0226] (+-)-(3E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (+-)-(1E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one, 3,7-dimethyl-2,6-nonadienenitrile,

[0227] 3,7-Dimethyl-3,6-nonadienenitrile,

[0228] 10-Methyl-α-ionone,

[0229] 10-Methyl-β-ionone,

[0230] 10-Methyl-γ-ionone,

[0231] (1E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1-penten-3-one,

[0232] (+)-3,3-dimethyl-5-[(1S)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol,

[0233] (+-)-6-propyltetrahydro-2H-pyran-2-one,

[0234] (1RS,4aSR,8RS,8aSR)-2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a-octahydro-1-naphthol,

[0235] (3Z)-3-hexen-1-yl hexanoate,

[0236] 2,4,6,8-Tetramethylnonyl acetate,

[0237] (-)-3,3-dimethyl-5-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol,

[0238] (2RS,4aRS,8aSR)-5,5,8a-trimethyldecahydro-2-naphthyl acetate,

[0239] (2S,5R)-5-methyl-2-(2-propyl)cyclohexanone oxime,

[0240] 2,6,10,10-Tetramethyl-1-oxaspiro[4.5]decan-6-ol,

[0241] (4Z)-4-Dodecenenitrile,

[0242] Dodecanonitrile,

[0243] Thymol,

[0244] Propionic acid tricyclo[5.2.1.0(2,6)]dec-3-en-8-yl ester,

[0245] Propionic acid tricyclo[5.2.1.0(2,6)]dec-4-en-8-yl ester,

[0246] 2-tert-Butyl-1,4-dimethoxybenzene,

[0247] (+-)-(3E)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one,

[0248] (3E)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one,

[0249] 4-Methyl-6-phenyl-2-hexanol,

[0250] 9-Hydroxy-5,9-dimethyl-4-decenal;

[0251] 7-propyl-2H,4H-1,5-benzodioxepin-3-one,

[0252] Allyl phenoxyacetate,

[0253] (3aRS,5aSR,9aSR,9bRS)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan,

[0254] (3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan,

[0255] (3aRS,5aSR,9aSR,9bRS)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan,

[0256] (3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan,

[0257] (+-)-2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol,

[0258] (E)-3-phenyl-2-propenyl propionate,

[0259] [3-oxo-2-pentylcyclopentyl]acetic acid methyl ester,

[0260] 2-Benzopyrone,

[0261] (+-)-4-Decalactone,

[0262] (+-)-5-octyldihydro-2(3H)-furanone,

[0263] (+-)-6-Heptyltetrahydro-2H-pyran-2-one,

[0264] (+-)-3-(1,3-benzodioxol-5-yl)-2-methylpropanal,

[0265] 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal,

[0266] 3-(1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal,

[0267] 2-Methylpropionic acid 4-formyl-2-methoxyphenyl ester,

[0268] (+-)-8-sec-butylquinoline,

[0269] (+-)-6-sec-butylquinoline,

[0270] (+-)-6-[(2Z)-2-penten-1-yl]tetrahydro-2H-pyran-2-one,

[0271] 2-Ethoxy-4-(methoxymethyl)phenol,

[0272] 1-(2-Naphthyl)ethylene ketone,

[0273] (4E)-4-methyl-5-(4-methylphenyl)-4-pentenal,

[0274] 2-{2-[(1R)-4-methyl-3-cyclohexen-1-yl]propyl}cyclopentanone,

[0275] (+)-(4R,4aS,6R)-4,4a-dimethyl-6-(1-propen-2-yl)-4,4a,5,6,7,8-hexahydro-2(3H)-naphthalenone,

[0276] 1-[2,2,6-trimethylcyclohexyl]-3-hexanol,

[0277] 2-Tridecenenitrile,

[0278] 3-Tridecenenitrile,

[0279] 4-Methylphenyl phenylacetate,

[0280] (+-)-3-methyl-5-phenyl-1-pentanol,

[0281] (+-)-2,3,3-Trimethyl-1-indanone,

[0282] 2-(4-methyl-1,3-thiazol-5-yl)-1-ethanol,

[0283] 7-(2-methyl-2-n-propyl)-2H-1,5-benzodioxepin-3(4H)-one,

[0284] (E)-2-Tridecene aldehyde,

[0285] 6-Hexyltetrahydro-2H-pyran-2-one,

[0286] 2-Methoxy-4-methylphenyl methyl carbonate,

[0287] (+)-(1S,2S,3S,5R)-2,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,1'-cyclohexane]-2'-en-4'-one,

[0288] (1S,4S,9S,10R,13R)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane,

[0289] (1R,4S,9S,10R,13S)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane, and any combination thereof;

[0290] The volatility of the Group B components described herein may be from 100 μg / L to 10 μg / L, or from 10 μg / L to 0.001 μg / L.

[0291] The Group B component with a volatility of 100 μg / L to 10 μg / L described herein is selected from the group consisting of:

[0292] 1-(4-methoxyphenyl)-1-ethanone,

[0293] (+-)-8α,8A-Epoxy-perhydro-2β,5,5-trimethyl-2-trans-naphthol,

[0294] (+-)-4A,8A-Epoxy-perhydro-2,5,5-trimethyl-2-naphthol,

[0295] (+-)-4-(C-2,3-epoxy-2,6,6-trimethyl-R-1-cyclohexyl)-2-butanone,

[0296] 4-Methoxybenzyl acetate,

[0297] 4-Methoxy-1-benzyl alcohol,

[0298] (E)-2-Methyl-2-butenoic acid benzyl ester,

[0299] (+-)-1,1,2,3,3-pentamethyl-1,2,3,5,6,7-hexahydro-4H-inden-4-one,

[0300] Cedre-8-ene,

[0301] 1-(Cedre-8-en-9-yl)vinyl ketone,

[0302] (2E)-3-phenyl-2-propen-1-ol,

[0303] (E)-3-phenyl-2-propenal,

[0304] (E)-3-phenyl-2-propenyl acetate,

[0305] 3-methyl-2-[(2Z)-2-penten-1-yl]-2-cyclopenten-1-one,

[0306] 3-Hydroxy-2-methyl-4H-pyran-4-one,

[0307] Allyl (cyclohexyloxy)acetate,

[0308] 2-Methoxy-4-propylphenol,

[0309] 4-Methyl-2-phenyltetrahydro-2H-pyran,

[0310] (2E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one,

[0311] (E)-3-phenyl-2-propenoic acid ethyl ester,

[0312] 3-(4-ethylphenyl)-2,2-dimethylpropanal,

[0313] 3-(2-ethylphenyl)-2,2-dimethylpropanal,

[0314] (+-)-3-(3-isopropyl-1-phenyl)butyraldehyde,

[0315] (+-)-(E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one,

[0316] (E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one,

[0317] (+-)-(E)-1-(2,2-dimethyl-6-methylene-1-cyclohexyl)-1-penten-3-one,

[0318] (E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1-penten-3-one,

[0319] (E)-3,7-dimethyl-2,6-octadien-1-ol,

[0320] Benzo[d][1,3]dioxole-5-carboxaldehyde,

[0321] (+-)-(3E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one,

[0322] (+-)-(1E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one,

[0323] (+-)-(E)-trans-α-irone,

[0324] (+-)-(E)-cis-α-irone,

[0325] (+-)-(E)-β-irone,

[0326] (+-)-(3E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one,

[0327] (+-)-(1E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one,

[0328] 3,7-Dimethyl-2,6-nonadienenitrile,

[0329] 3,7-Dimethyl-3,6-nonadienenitrile,

[0330] 10-Methyl-α-ionone,

[0331] 10-Methyl-β-ionone,

[0332] 10-Methyl-γ-ionone,

[0333] (1E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1-penten-3-one,

[0334] (+)-3,3-dimethyl-5-[(1S)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol,

[0335] (+-)-6-propyltetrahydro-2H-pyran-2-one,

[0336] (1RS,4aSR,8RS,8aSR)-2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a-octahydro-1-naphthol,

[0337] (3Z)-3-hexen-1-yl hexanoate,

[0338] 2,4,6,8-Tetramethylnonyl acetate,

[0339] (-)-3,3-dimethyl-5-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol,

[0340] (2RS,4aRS,8aSR)-5,5,8a-trimethyldecahydro-2-naphthyl acetate,

[0341] (2S,5R)-5-methyl-2-(2-propyl)cyclohexanone oxime,

[0342] 2,6,10,10-Tetramethyl-1-oxaspiro[4.5]decan-6-ol,

[0343] (4Z)-4-Dodecenenitrile,

[0344] Dodecanonitrile,

[0345] Thymol,

[0346] Propionic acid tricyclo[5.2.1.0(2,6)]dec-3-en-8-yl ester,

[0347] Propionic acid tricyclo[5.2.1.0(2,6)]dec-4-en-8-yl ester,

[0348] 2-tert-Butyl-1,4-dimethoxybenzene,

[0349] (+-)-(3E)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one,

[0350] (3E)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one,

[0351] 4-Methyl-6-phenyl-2-hexanol,

[0352] 9-Hydroxy-5,9-dimethyl-4-decenal,

[0353] and any combination thereof.

[0354] The Group B component with a volatility of 10 μg / L to 0.001 μg / L described herein is selected from the group consisting of:

[0355] 7-propyl-2H,4H-1,5-benzodioxepin-3-one,

[0356] Allyl phenoxyacetate,

[0357] (3aRS,5aSR,9aSR,9bRS)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan,

[0358] (3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan,

[0359] (3aRS,5aSR,9aSR,9bRS)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan,

[0360] (3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan,

[0361] (+-)-2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol,

[0362] (E)-3-phenyl-2-propenyl propionate,

[0363] [3-oxo-2-pentylcyclopentyl]acetic acid methyl ester,

[0364] 2-Benzopyrone,

[0365] (+-)-4-Decalactone,

[0366] (+-)-5-octyldihydro-2(3H)-furanone,

[0367] (+-)-6-Heptyltetrahydro-2H-pyran-2-one,

[0368] (+-)-3-(1,3-benzodioxol-5-yl)-2-methylpropanal,

[0369] 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal,

[0370] 3-(1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal,

[0371] 2-Methylpropionic acid 4-formyl-2-methoxyphenyl ester,

[0372] (+-)-8-sec-butylquinoline,

[0373] (+-)-6-sec-butylquinoline,

[0374] (+-)-6-[(2Z)-2-penten-1-yl]tetrahydro-2H-pyran-2-one,

[0375] 2-Ethoxy-4-(methoxymethyl)phenol,

[0376] 1-(2-Naphthyl)ethylene ketone,

[0377] (4E)-4-methyl-5-(4-methylphenyl)-4-pentenal,

[0378] 2-{2-[(1R)-4-methyl-3-cyclohexen-1-yl]propyl}cyclopentanone,

[0379] (+)-(4R,4aS,6R)-4,4a-dimethyl-6-(1-propen-2-yl)-4,4a,5,6,7,8-hexahydro-2(3H)-naphthalenone,

[0380] 1-[2,2,6-trimethylcyclohexyl]-3-hexanol,

[0381] 2-Tridecenenitrile,

[0382] 3-Tridecenenitrile,

[0383] 4-Methylphenyl phenylacetate,

[0384] (+-)-3-methyl-5-phenyl-1-pentanol,

[0385] (+-)-2,3,3-Trimethyl-1-indanone,

[0386] 2-(4-methyl-1,3-thiazol-5-yl)-1-ethanol,

[0387] 7-(2-methyl-2-n-propyl)-2H-1,5-benzodioxepin-3(4H)-one,

[0388] (E)-2-Tridecene aldehyde,

[0389] 6-Hexyltetrahydro-2H-pyran-2-one,

[0390] 2-Methoxy-4-methylphenyl methyl carbonate,

[0391] (+)-(1S,2S,3S,5R)-2,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,1'-cyclohexane]-2'-en-4'-one,

[0392] (1S,4S,9S,10R,13R)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane,

[0393] (1R,4S,9S,10R,13S)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane, and any combination thereof.

[0394] In one embodiment, the at least two B group components are present in an amount of at least 1% by weight relative to the total weight of the composition, typically at least 3%, more typically at least 4%. In another embodiment, the at least two B group components are present in an amount of 1% to 95% by weight relative to the total weight of the composition, typically 3% to 80%, more typically 4% to 70%.

[0395] In one embodiment, at least one of the at least two Group A components and / or at least one of the at least two Group B components has a volatility of 10 μg / L to 0.001 μg / L. In another embodiment, at least one of the at least two Group A components and at least one of the at least two Group B components have a volatility of 10 μg / L to 0.001 μg / L. In yet another embodiment, at least one of the at least two Group A components or at least one of the at least two Group B components has a volatility of 10 μg / L to 0.001 μg / L.

[0396] In one embodiment, at least one of the two Group A components and / or at least one of the at least two Group B components has a volatility of 100 μg / L to 10 μg / L. In another embodiment, at least one of the two Group A components and at least one of the at least two Group B components have a volatility of 100 μg / L to 10 μg / L. In yet another embodiment, at least one of the two Group A components or at least one of the at least two Group B components has a volatility of 100 μg / L to 10 μg / L.

[0397] Certain Group A components are particularly useful when used in the fragrance compositions described herein. In one embodiment, at least one of the at least two Group A components is selected from the group consisting of:

[0398] (+-)-2-[4-(2-hydroxy-2-methylpropyl)phenyl]propanal,

[0399] 3-(3-(2-hydroxy-2-methylpropyl)phenyl)propanal,

[0400] 3-[4-(2-Hydroxy-2-methylpropyl)phenyl]propanal,

[0401] (+-)-1-(5-propyl-1,3-benzodioxol-2-yl) ketene,

[0402] (3S,3aR,5R,8S,8aS)-5-isopropenyl-3,8-dimethyloctahydro-3a(1H)-azulenol,

[0403] 7-isopropenyl-1,4-dimethyldecahydro-4-azulenol,

[0404] (1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane-3-ol,

[0405] (1R,3R,6S,7S,8S)-3-ethoxy-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane,

[0406] (+-)-6-methyl-7-oxa-1-thia-4-azaspiro[4.4]nonane,

[0407] (2E)-2-Dodecenal,

[0408] (+-)-4-Methylene-2-phenyltetrahydro-2H-pyran,

[0409] (+-)-4-methyl-6-phenyl-3,6-dihydro-2H-pyran,

[0410] (+-)-4-methyl-2-phenyl-3,6-dihydro-2H-pyran,

[0411] 3,6-Dimethylhexahydro-1-benzofuran-2(3H)-one,

[0412] (+-)-1-(5-ethyl-5-methyl-1-cyclohexen-1-yl)-4-penten-1-one,

[0413] (-)-(1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane-3-ol,

[0414] 1-Oxaspiro[4.5]decan-2-one,

[0415] (4Z)-4-Dodecenal,

[0416] 3-propylphenol, and any combination thereof.

[0417] Certain B group ingredients are also particularly useful when used in the fragrance compositions described herein. In one embodiment, at least one of the at least two B group ingredients is selected from the group consisting of:

[0418] 7-propyl-2H,4H-1,5-benzodioxepin-3-one,

[0419] (4E)-4-methyl-5-(4-methylphenyl)-4-pentenal,

[0420] 7-(2-methyl-2-n-propyl)-2H-1,5-benzodioxepin-3(4H)-one,

[0421] 2-Methoxy-4-methylphenyl methyl carbonate,

[0422] (+)-(1S,2S,3S,5R)-2,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,1'-cyclohexane]-2'-en-4'-one,

[0423] (1S,4S,9S,10R,13R)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane,

[0424] (1R,4S,9S,10R,13S)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane,

[0425] (+)-3,3-dimethyl-5-[(1S)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol,

[0426] (1RS,4aSR,8RS,8aSR)-2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a-octahydro-1-naphthol,

[0427] (2RS,4aRS,8aSR)-5,5,8a-trimethyldecahydro-2-naphthyl acetate,

[0428] (2S,5R)-5-methyl-2-(2-propyl)cyclohexanone oxime,

[0429] 2,6,10,10-Tetramethyl-1-oxaspiro[4.5]decan-6-ol,

[0430] 4-methyl-6-phenyl-2-hexanol, and any combination thereof.

[0431] The fragrance composition may further comprise at least 0.1%, typically at least 2%, more typically at least 4% by weight relative to the total weight of the composition of at least two ingredients selected from A' component, B' component or a combination thereof, each of the at least two ingredients having a volatility range of 1000 μg / L to 100 μg / L, wherein the A' component is selected from the group consisting of:

[0432] 1-(Pyrazinyl)-1-ethanone,

[0433] (+-)-2-Methylundecanal,

[0434] 10-Undecenal,

[0435] 9-Undecenal,

[0436] Allyl (3-methylbutoxy)acetate,

[0437] (2-Methylbutoxy)acetic acid (+-)-allyl ester,

[0438] (-)-(5R)-5-isopropenyl-2-methyl-2-cyclohexen-1-one,

[0439] (+-)-3-Mercaptohexyl acetate,

[0440] (Z)-4-Decenal,

[0441] (2E)-1-[(1RS,2SR)-2,6,6-trimethyl-3-cyclohexen-1-yl]-2-buten-1-one,

[0442] 4-Ethyl-2-methoxyphenol,

[0443] 4,6,6-Trimethyl-1,3-cyclohexadiene-1-carboxylic acid ethyl ester,

[0444] (+-)-4-Hydroxy-2,5-dimethyl-3(2H)-furanone,

[0445] (3E,5Z)-1,3,5-Undecatriene,

[0446] (+-)-Perhydro-4α,8Aβ-dimethyl-4A-naphthol,

[0447] 2-Methoxyphenol,

[0448] 8-isopropyl-6-methyl-bicyclo[2.2.2]oct-5-ene-2-carbaldehyde,

[0449] 2-Hexyl-2-cyclopenten-1-one,

[0450] 2-Methoxy-3-(4-methylpentyl)pyrazine,

[0451] 2-Octynoic acid methyl ester,

[0452] 1-(4-Methylphenyl) ketene,

[0453] (+-)-2-Methyldecanal,

[0454] (2E,6Z)-1,1-diethoxy-2,6-nonadiene,

[0455] (Z)-2-nonenal,

[0456] 2-Hydroxy-3-methyl-2-cyclopenten-1-one,

[0457] γ-octanolactone,

[0458] 2,6,6-Trimethyl-2-cyclohexene-1,4-dione,

[0459] 4-Methylphenol,

[0460] 4-Methylphenyl acetate,

[0461] 4-Methylphenyl isobutyrate,

[0462] (+-)-cis-tetrahydromethyl-4-methylene-6-phenyl-2H-pyran,

[0463] (+-)-cis-3,6-dihydro-4,6-dimethyl-2-phenyl-2H-pyran,

[0464] (+-)-cis-3,6-dihydro-2,4-dimethyl-6-phenyl-2H-pyran,

[0465] (2E,6Z)-2,6-nonadienal,

[0466] (2E,6Z)-2,6-nonadien-1-ol,

[0467] 3-phenylpropanal,

[0468] 3-(6,6-Dimethyl-bicyclo[3.1.1]hept-2-en-2-yl)propanal,

[0469] (+-)-2,4-dimethyl-4-phenyltetrahydrofuran,

[0470] 2,6,6-Trimethyl-1,3-cyclohexadiene-1-carbaldehyde,

[0471] (1R,4R)-8-Mercapto-3-menthone,

[0472] (4E)-4-Decenal,

[0473] 2-Ethoxy-4-methylphenol,

[0474] (+-)-(4Z)-4-cycloocten-1-yl methyl carbonate,

[0475] 2,6-nonadienenitrile,

[0476] (+-)-2-(4-methyl-3-cyclohexen-1-yl)-2-propanethiol, and any combination thereof; and

[0477] The B' group components are selected from the group consisting of:

[0478] Decanal,

[0479] Dodecanal,

[0480] 1-methoxy-4-[(1E)-1-propen-1-yl]benzene,

[0481] 4-phenyl-2-butanone,

[0482] (+)-(5S)-5-isopropenyl-2-methyl-2-cyclohexen-1-one,

[0483] (+)-(R)-3,7-dimethyl-6-octenal,

[0484] (+-)-3,7-dimethyl-6-octenal,

[0485] 5,9-Dimethyl-4-decenal,

[0486] 2-Methoxy-4-methylphenol,

[0487] 3-Hexenoic acid cyclopropyl methyl ester,

[0488] (+-)-2-Pentylcyclopentanone,

[0489] (+-)-2,6-dimethyl-7-octen-2-ol, 3,7-dimethyl-1,6-nonadien-3-ol, ethyl phenylacetate,

[0490] 2-Methyl-1,3-dioxolane-2-acetic acid ethyl ester, 3-(2,2-dimethylpropyl)pyridine,

[0491] tricyclo[5.2.1.0.(2,6)]decane-2-carboxylic acid ethyl ester, formic acid (+-)-3,7-dimethyl-6-octen-1-yl ester, formic acid (2E)-3,7-dimethyl-2,6-octadien-1-yl ester, 3,7-dimethyl-2,6-octadienenitrile,

[0492] (+-)-4-Heptanolide,

[0493] 1-Phenylvinyl acetate,

[0494] (8E)-8-Undecenal,

[0495] 10-Undecenal,

[0496] (9E)-9-Undecenal,

[0497] (+)-3-[(1R)-4-methyl-3-cyclohexen-1-yl]butanal, (+-)-3,7-dimethyl-1,6-octadien-3-ol, methyl phenylacetate,

[0498] (+-)-2-Methyldecanenitrile,

[0499] 2-Phenylethyl acetate,

[0500] 2-phenylethanol,

[0501] 2-Acetyl-4-methyl-4-pentenoic acid (+-)-ethyl ester, (Z)-3-nonenyl acetate,

[0502] (Z)-6-nonenyl acetate,

[0503] (Z,Z)-3,6-nonadienyl acetate,

[0504] (2E,6Z)-2,6-nonadienyl acetate, 3-(4,4-dimethyl-1-cyclohexen-1-yl)propanal,

[0505] (+-)-3-phenylbutyraldehyde,

[0506] 2-Methyl-3-hexanone oxime,

[0507] 1,3-Undecadien-5-yne,

[0508] (+-)-4-methoxy-2,5-dimethyl-3(2H)-furanone,

[0509] (+-)-6-methoxy-2,6-dimethylheptanal, and any combination thereof.

[0510] The fragrance composition according to the present disclosure may also include at least 0.1% by weight, typically at least 2% by weight, more typically at least 4% by weight of at least two ingredients selected from A" components, B" components or a combination thereof, relative to the total weight of the composition, wherein the volatility of each of the at least two ingredients is greater than or equal to 1000 μg / L, wherein the A" component is selected from the group consisting of:

[0511] 1-(2-Pyridyl)-1-ethanone,

[0512] 2,3-Pentanedione,

[0513] 1-(1,3-thiazol-2-yl)-1-ethanone,

[0514] Heptanal,

[0515] Octanal,

[0516] (+-)-2-Methylvalerate Ethyl ester,

[0517] 2-Furanmethylthiol,

[0518] (+-)-1-octen-3-ol,

[0519] (Z)-6-nonenal,

[0520] 4-Mercapto-4-methyl-2-pentanone,

[0521] (1RS,6RS)-3,6-dimethyl-3-cyclohexene-1-carbaldehyde,

[0522] 4,6-Dimethyl-3-cyclohexene-1-carbaldehyde,

[0523] 2-Methylbutyric acid (+-)-ethyl ester,

[0524] Ethyl benzoate,

[0525] Ethyl butyrate,

[0526] Ethylhexanoate,

[0527] 3-Ethyl-2,5-dimethylpyrazine,

[0528] 2-Ethyl-3,5-dimethylpyrazine,

[0529] Ethyl isobutyrate,

[0530] 2-Ethyl-3-methylpyrazine,

[0531] 5-methyl-2-hepten-4-one,

[0532] 2-Isopropyl-3-methoxypyrazine,

[0533] (+-)-2,6-dimethyl-5-heptenal,

[0534] 2-Methoxy-3-methylpyrazine,

[0535] 2-Methoxy-6-methylpyrazine,

[0536] 2-isopropyl-4-methylthiazole,

[0537] Diallyl disulfide,

[0538] (1R,5R)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]oct-3-ene,

[0539] (1R,4R,5R)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane, 1-decene-4-yne,

[0540] Butylpyrazole (PYRAZOBUTYLE),

[0541] 2-Methoxy-3-(1-methylpropyl)pyrazine,

[0542] 2,2-Dimethyl-6-methylidenecyclohexanecarboxylic acid (+-)-methyl ester,

[0543] (+-)-2-ethyl-4,4-dimethyl-1,3-oxathiinane,

[0544] (+-)-1-methoxy-3-hexanethiol,

[0545] 2,3,5-Trimethylpyrazine,

[0546] Trimethylamine,

[0547] 3-Methyl-2-oxopentanoic acid (+-)-ethyl ester,

[0548] 2,4-dimethyl-3-cyclohexene-1-carbaldehyde, and any combination thereof; and the B" component is selected from the group consisting of:

[0549] Acetophenone,

[0550] (+-)-3-Hydroxy-2-butanone,

[0551] Hexanal,

[0552] Nonanal,

[0553] 3-Methylbutyl propionate,

[0554] 2-Methylbutyl propionate,

[0555] (2E)-2-methyl-2-hexenoic acid methyl ester,

[0556] 1,1-diethoxy-3,7-dimethyl-2,6-octadiene,

[0557] Cyclohexyl acetate,

[0558] Dibutyl sulfide,

[0559] 1,3,3-Trimethyl-2-oxabicyclo[2.2.2]octane,

[0560] (+)-(1R,2R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol, 2-phenylpropanal,

[0561] 3,5,6-Trimethyl-3-cyclohexene-1-carbaldehyde,

[0562] 2,4,6-Trimethyl-3-cyclohexene-1-carbaldehyde,

[0563] Methyl 3-(methylthio)propionate,

[0564] 1-Methoxy-4-methylbenzene,

[0565] 7-Methyl-3-methylene-1,6-octadiene,

[0566] (3Z)-1-[2-buten-1-yloxy]-3-hexene,

[0567] 2-Methyl-4-propyl-1,3-oxathiinane,

[0568] (2-methoxyethyl)benzene,

[0569] (Z)-3-hexenyl acetate,

[0570] (Z)-3-Hexenyl formate,

[0571] 4-methyl-2-(2-methyl-1-propen-1-yl)tetrahydro-2H-pyran,

[0572] 2,2-Dimethylpropanoic acid (-)-(2S)-1-oxo-1-(2-n-propoxy)-2-n-propyl ester,

[0573] (2E)-2-octen-4-one,

[0574] (2E)-2-hexenal, and any combination thereof.

[0575] The fragrance composition may also contain additional ingredients commonly used in the perfume industry, such as perfume carriers.

[0576] As used herein, "fragrance carrier" refers to a material that is virtually neutral from a fragrance point of view, i.e., does not significantly change the sensory properties of the fragrance ingredients. The carrier can be liquid or solid. Exemplary liquid carriers include, but are not limited to, emulsifying systems, i.e., solvents and surfactant systems, or solvents commonly used in the fragrance industry. A detailed description of the properties and types of solvents commonly used in the fragrance industry is not exhaustive. However, suitable solvents include, but are not limited to, glycols, such as propylene glycol or butylene glycol; glycerol; dipropylene glycol and its monoethers, 1,2,3-propanetriol triacetate, dimethyl glutarate, dimethyl adipate, 1,3-diacetoxyprop-2-yl acetate, diethyl phthalate, isopropyl myristate, rosin resins (e.g., available from Eastman ), benzyl benzoate, benzyl alcohol, 2-(2-ethoxyethoxy)-1-ethanol, triethyl citrate, and mixtures thereof; and naturally derived solvents such as glycerol and vegetable oils, including palm oil, sunflower oil, linseed oil, and mixtures thereof. In some cases, for example, the fragrance carrier may be ethanol, a water / ethanol mixture, limonene or other terpenes, isoparaffins, such as those sold under the trademark Those known in the art (available from Exxon Chemical), or glycol ethers and glycol ether esters, such as those sold under the trademark Those known as castor oils (available from Dow Chemical Company), or hydrogenated castor oils, such as those sold under the trademark RH 40 is known among those (available from BASF).

[0577] Solid carrier refers to a material to which a fragrance composition or certain components of a fragrance composition can be chemically or physically bound. Generally speaking, such solid carriers are used to stabilize the composition, or to control the evaporation rate of the composition or certain components. Solid carriers are currently used in the art, and those skilled in the art know how to achieve the desired effect. Suitable solid carriers include, but are not limited to, absorbent glues or polymers or inorganic materials, such as porous polymers, cyclodextrins, dextrins, maltodextrins, wood-based materials, organic or inorganic gels, clays, gypsum, talc or zeolites.

[0578] Other suitable solid carriers include encapsulating materials. Examples of such materials may include wall-forming materials and plasticizers, such as glucose syrup, natural or modified starch, hydrocolloids, cellulose derivatives, polyvinyl acetate, polyvinyl alcohol, proteins or pectins, plant gums such as acacia gum (gum arabic), urea, sodium chloride, sodium sulfate, zeolite, sodium carbonate, sodium bicarbonate, clay, talc, calcium carbonate, magnesium sulfate, gypsum, calcium sulfate, magnesium oxide, zinc oxide, titanium dioxide, calcium chloride, potassium chloride, magnesium chloride, zinc chloride, carbohydrates, sugars such as sucrose, monosaccharides, disaccharides, trisaccharides and polysaccharides and derivatives such as chitosan, starch, cellulose, carboxymethyl methylcellulose, methyl Cellulose, hydroxyethylcellulose, ethylcellulose, propylcellulose, polyols / sugar alcohols such as sorbitol, maltitol, xylitol, erythritol and isomalt, polyethylene glycol (PEG), polyvinyl pyrrolidone (PVP), polyvinyl alcohol, acrylamide, acrylates, polyacrylic acid and related substances, maleic anhydride copolymers, amine functional polymers, vinyl ethers, styrene, polystyrene sulfonates, vinyl acid, ethylene glycol-propylene glycol block copolymers, vegetable gums, acacia gum, pectin, xanthan gum, alginates, carrageenan, citric acid or any water-soluble solid acid, fatty alcohol or fatty acid and mixtures thereof.

[0579] Other suitable encapsulating materials are described in references known to the person skilled in the art, for example H. Scherz, Hydrokolloide: Stabilisatoren, Dickungs- und Geliermittel in Lebensmitteln, Band2 der Schriftenreihe Lebensmittelchemie, Behr's Verlag GmbH & Co., Hamburg, 1996. Encapsulation is a process well known to the person skilled in the art and may be performed, for example, using techniques such as spray drying, agglomeration or extrusion; or consist of coating encapsulation including coacervation and complex coacervation techniques.

[0580] Other exemplary solid supports include core-shell capsules having aminoplast, polyamide, polyester, polyurea or polyurethane type resins and mixtures thereof, which are prepared using techniques well known to those skilled in the art, such as by polymerization-induced phase separation, interfacial polymerization, coacervation or a combination thereof, optionally in the presence of a polymer stabilizer or a cationic copolymer.

[0581] The resins may be produced by polycondensation of aldehydes such as formaldehyde, 2,2-dimethoxyacetaldehyde, glyoxal, glyoxylic acid or glycolaldehyde and mixtures thereof with amines such as urea, benzoguanamine, glycoluril, melamine, methylolmelamine, methylated methylolmelamine, guanazole, and the like and mixtures thereof. Alternatively, preformed resins may be used, such as those sold under the trademark (Source: Cytec Technology Corp.), (Source: Cytec TechnologyCorp.), or (Source: BASF) Those that are commercially available.

[0582] Other suitable resins are prepared by reacting a polyol such as glycerol with a polyisocyanate such as a trimer of hexamethylene diisocyanate, a trimer of isophorone diisocyanate or xylylene diisocyanate or the biuret of hexamethylene diisocyanate, or a trimer of xylylene diisocyanate and trimethylolpropane (known under the trade name Those produced by polycondensation of xylylene diisocyanate (source: Mitsui Chemicals), of which the trimer of xylylene diisocyanate with trimethylolpropane and the biuret of hexamethylene diisocyanate are preferred.

[0583] Encapsulation of fragrances by condensation of amino resins, i.e., melamine-based resins, with aldehydes is well known in the art. Relevant publications include, but are not limited to, Acta Polymerica, 1989, vol. 40, pages 243, 325, and 683 by K. Dietrich et al., and 1990, vol. 41, page 91, and U.S. Pat. No. 4,396,670 issued on August 2, 1983. General knowledge of encapsulation technology is very important and cannot be exhaustive. More recent targeted publications also relate to suitable uses of such microcapsules, representative articles such as K. Bruyninckx and M. Dusselier, ACS Sustainable Chemistry & Engineering, 2019, vol. 7, pages 8041-8054. These publications are incorporated herein by reference.

[0584] The fragrance composition may optionally comprise at least one fragrance adjuvant.

[0585] The at least one perfume adjuvant is an ingredient capable of imparting additional additional benefits such as colour, specific lightfastness, chemical stability, etc. A detailed description of the nature and types of adjuvants commonly used in perfuming compositions cannot be exhaustive, but it must be mentioned that said ingredients are well known to the person skilled in the art.

[0586] Exemplary perfume adjuvants include, but are not limited to, viscosity agents (e.g., surfactants, thickeners, gelling agents and / or rheology modifiers), stabilizers (e.g., preservatives, antioxidants, heat / light and / or buffers or chelating agents, such as BHT), colorants (e.g., dyes and / or pigments), preservatives (e.g., antibacterial or antimicrobial or antifungal or anti-irritants), abrasives, skin cooling agents, fixatives, insect repellents, ointments, vitamins, and mixtures thereof.

[0587] A fixative, also called a "fixative", is an agent that has the ability to affect the way an observer or user perceives the odor of a composition into which it is incorporated, particularly the rate of evaporation and the intensity, over time, compared to the same perception without the fixative. In particular, the fixative allows the perception of its fragrance to be prolonged. Suitable fixatives include, but are not limited to: methyl glucoside polyol; ethyl glucoside polyol; propyl glucoside polyol; isocetyl alcohol; PPG-3 myristyl ether; neopentyl glycol diethylhexanoate; sucrose laurate; sucrose dilaurate, sucrose myristate, sucrose palmitate, sucrose stearate, sucrose distearate, sucrose tristearate, hyaluronate disaccharide sodium salt, sodium hyaluronate, propylene glycol propyl ether; dicetyl ether; polyglyceryl-4 ether; isoceteth-5; isoceteth -7, isoceteth-10; isoceteth-12; isoceteth-15; isoceteth-20; isoceteth-25; isoceteth-30; disodium laurylamphodipropionate; hexaethylene glycol monododecyl ether; and mixtures thereof; neopentyl glycol diisononanoate; cetearyl ethylhexanoate; panthenol ethyl ether, DL-panthenol, hexadecyl nonanoate, hexadecyl nonanoate, fragrance precursors, cyclodextrins, encapsulating agents, and any combination thereof. In one embodiment, the fragrance further comprises a fixative.

[0588] The fragrance compositions described herein may also include one or more other odorant ingredients, as long as the presence and / or concentration of the odorant ingredients does not alter the long-lasting fragrance performance of the composition. Such odorant ingredients include, but are not limited to: (+-)-1-(3-cycloocten-1-yl)-1-propanol, ethyl cyclohexanecarboxylate, 7-(3-methylbutyl)-2H-1,5-benzodioxepin-3(4H)-one, (E)-4,7-octadienoic acid methyl ester, 11-oxa-16-hexadecanoic acid, (2E,5Z)-5,6,7-trimethyl-2,5-octadien-4-one, 3-methyl-5-cyclotetradecene-1-one, (+-)-2-tert-butyl-5-methyl-2-propyl-2,5-dihydrofuran, (+-)-(Z)-1-(3-cycloocten-1-yl)ethanone, 2-ethyl-N-methyl-N-(3-methylphenyl)butyramide, water Salicylic acid (3Z)-1-methyl-3-hexenyl ester, (+-)-6-methoxy-2,6-dimethyloctanal, cyclohexylidene (2-methylphenyl) acetonitrile, (+-)-2-(2,2,7,7-tetramethyltricyclo[6.2.1.0~1,6~]undec-5-en-5-yl)-1-propanol, (+-)-4-vinyl-1-cyclohexene-1-carbaldehyde, cyclopropanecarboxylic acid (+-)-2-[(3,5-dimethyl-3-hexen-2-yl)oxy]-2-methylpropyl ester, (+-)-1-methoxy-7,9-dimethyl-2-oxaspiro[5.5]undec-8-ene, (+-)-1-ethoxy-7,9-dimethyl-2-oxaspiro[5.5] undec-8-ene, (3S,5R,8S)-5-isopropenyl-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydro-1-azulenol, (+-)-8-(2-n-butyl)-5,6,7,8-tetrahydroquinoline, (4Z)-9-hydroxy-5,9-dimethyl-4-decenal, (+-)-2-[(1E)-3-ethoxy-1-buten-1-yl]-1,3,3-trimethylcyclohexane Hexene, 3-(4-isobutyl-2-methylphenyl) propanal, (+-)-[1-methyl-2-(5-methyl-4-hexen-2-yl) cyclopropyl] methanol, (+-)-2,4,7-trimethyl-6-octen-1-ol, 2-methylbenzoic acid methyl ester, 3-methyl-1-cyclohexanecarboxylic acid (+-)-methyl ester, (+-)-1-(2,4-dimethyl-3-cyclohexen-1-yl)-1-propanol, 2-oxacycloheptan-2- Ketone, ((1RS,2RS)-2,4-dimethylcyclohex-3-enyl) methyl acetate, (+)-(1S)-1-[(1R)-3,3-dimethylcyclohexyl]ethyl malonate, (+)-(1S)-1-[(1R)-3,3-dimethylcyclohexyl]ethyl malonate, (+)-4-methyl-2-propyl-1,3-oxathiinane, ethyl 3-(1-cyclohexen-1-yl) propionate, (+ )-(1R,4S,9S,10R,13S)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane, 2,5-dimethyl-5-phenyl-1-hexen-3-one, cyclopropanecarboxylic acid (3Z)-3-hexenyl ester, (Z)-6-decenal, (1RS,2SR,6SR,7RS,8RS)-tricyclo[5.2.1.0(2,6)]dec-8-yl acetaldehyde, 3Aa-ethyl-perhydro-6,6,9Aa-trimethyl-5AbH,9BaH-naphtho[2,1-B]furan, 3-(4-isopropyl-1-phenyl)propanal, (+-)-3-ethyl-perhydro-benzo[B]furan-2-one, 5-methyl-5-phenyl-3-hexanone, (+-)-cis-2-ethyl-4-methyl-1,3-oxathiacyclohexane, (+-)-1-ethyl-2-(3-methylbutyl)-1-cyclopentanol, 3-(trans-4-isobutylcyclohexyl)propanal, methyl 2,4-dihydroxy-3-methylbenzoate, 1,1-dimethyl-2-phenyl isobutyrate, (+-)-2-methoxy-4-(4-methyl)- -3,6-dihydro-2H-pyran-2-yl)phenol, (+-)-2,2,6,6,7,8,8-heptamethyl-4,5,6,7,8,8b-hexahydro-3aH-indeno[4,5-d][1,3]dioxole, (+-)-4-(heptyloxy)-3-methylbutanal, (3E)-4-methyl-3-decen-5-one, (+-)-2-(5-isopropyl-2-methyltetrahydrothiophen-2-yl)ethanol, 4-methyl-2-oxocyclohexanecarboxylic acid (+-)-ethyl ester, bicyclo[2.2.1]hept-5-ene-2-carboxylic acid (1RS,2RS,4RS)-ethyl ester, (+-)-4,6-dimethyl-2-(1-phenylethyl)-3,6-dihydro- 2H-pyran, 2-methyl-1-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)-2-propanol, butyric acid tricyclo[5.2.1.0~2,6~]dec-3-en-8-yl ester, (+-)-7,7,8,9,9-pentamethyl-6,7,8,9-tetrahydro-5H-cyclopenta[h]quinazoline, (6aRS,9aRS)-7,7,8,9,9-pentamethyl-6,6a,7,8,9,9a-hexahydro-5H-cyclopenta[h]quinazoline, 5,7,8-trimethyltricyclo[5.2.1.0~2,6~]dec-8-ol, (2E)-2-butenoic acid (+-)-2-methyl-3-n-pentyl ester, 3-methyl-1-benzofuran- 5-ol, (-)-4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isobenzopyran, (+-)-3a-isopropyl-2,6-dimethyloctahydro-1-benzofuran, 5-(hexyloxy)-2,2-dimethyltetrahydrofuran, (+-)-4-ethylidene-2-propoxycyclohexanol, 3-[(1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]-2,2-dimethylpropionitrile, (+-)-(1E)-1-(4,6-dimethyl-3-cyclohexen-1-yl)-2-methyl-1-penten-3-one, (+-)-(3E)-3-(methoxymethylene)tricyclo[5.2.1.0~2,6~] decane, (2E,5E)-2-methoxy-6-methyl-2,5-octadiene, (14S)-14-methyloxahedraloxadiene-10-en-2-one, 5-propyltetrahydro-2H-pyran-2-one, (2Z)-(2,4,4-trimethylcyclopentylidene)acetonitrile, 6-cyclopentylidenehexanal, (4Z)-6-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-hexenal, (+-)-(2Z)-3,5,7-trimethyl-2-octenonitrile, 3,5,7-trimethyloctanonitrile, 6-(2,4,4-trimethylcyclopentylidene)hexanal, (1SR,6RS,8SR)-2,2-dimethyl-8-propyltricyclo[6.2.1.0~1,6~]undecan-7-one, 2,6-dimethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)cyclohex-2-en-1-ol, 5-(6-hepten-1-yl)dihydro-2(3H)-furanone, (+-)-(1Z,5E)-9-methoxy-2,5,10-trimethyl-1,5-cyclododecadiene, 2-(3,3-dimethyl-1-cyclohexen-1-yl)-2,5,5-trimethyl-1,3-dioxane, 8-cyclohexadecene -1-one, 4-decylpyridine, (+-)-8-exo-ethoxy-exo-tricyclo[5.2.1.0(2,6)]decane, (+-)-ethyl tetrahydro-2-furancarboxylate, 3-methyl-4-decanoyl lactone, (Z)-4-ethyl-3-octenonitrile, (+)-3-[(4R)-4-isopropyl-1-cyclohexen-1-yl]propanal, bicyclo[2.2.1]hept-5-en-2-yl acetate, (+-)-ethyl 2-cyclopenten-1-yl acetate, (+-)-2-methyldodecanal, 4-(3-methylbutyl)cyclohexanol, 6-methyl-4-(2,2,3-trimethyl-3 -cyclopenten-1-yl)-2-cyclohexen-1-ol, 2-((1RS,2SR)-2-ethylcyclohexyloxy)acetaldehyde, (+-)-5-cyclohexyl-2-methyl-1-pentanol, [(cis-4-methylcyclohexyl)oxy]acetaldehyde, {[cis-4-(2-n-propyl)cyclohexyl]oxy}acetaldehyde, {[trans-4-(2-methyl-2-n-propyl)cyclohexyl]oxy}acetaldehyde, (1R,3S,5R,7R,8R,10S,13R)-5,7,9,9,13-pentamethyl-5-propyl-4,6-dioxatetracyclo[6.5.1.0~1,10~.0~3,7~]tetradecane, (+-)-2-methyl-5-propyl-2-cyclohexene-1-one, 3,4-dimethylbenzonitrile, (2E)-2-methyl-2-butenedioic acid diethyl ester, 5-mercapto-5-methyl-3-hexanone, (+-)-3-(4-isobutylphenyl)-2-methylpropanal, (+-)-2,5,5-trimethyl-1, 2,3,4,4a,5,6,7-octahydro-2-naphthol, 3-mercapto-2-methylbutyric acid (+-)-ethyl ester, (-)-(3S,6E)-3,7,11-trimethyl-6,10-dodecadienal, (+)-(1S,2R)-1,2,3,3-tetramethyl-bicyclo[2.2.1]heptan-2-ol, (1S,4R)-1,2,3,3-tetramethyl Methyl-bicyclo[2.2.1]heptan-2-ol, 3-methyl-5-[(1R)-2,2,3-trimethylcyclopentyl]-2-pentanone, 2-ethoxy-4-(hydroxymethyl)phenol, 2-hydroxypropionic acid (+-)-3-cyclohexen-1-yl methyl ester, 2-methoxy-2-methylheptane, (1R,6S)-2,2,6-trimethylcyclohexanecarboxylic acid allyl ester, (+-)-6-hydroxy-2,6-dimethylheptanal, 3-methyl-2-pentyl-2-cyclopenten-1-one, 2,2-dimethyl-3-(3-methylphenyl)-1-propanol, BELLANONE, CANTALOOP, CEYLANIL, CYCLAMENTIOL, DIVINIRIS, EDENFLOR, FLOWERPOOL, etc.

[0589] The performance of the scent trace, typically the performance of the persistent scent trace, can be measured using methods and instruments known to those of ordinary skill in the art. Exemplary methods and instruments are described in U.S. Patent Publication No. 20190128782 (Luetkenhaus et al.), U.S. Patent No. 6,067,842 (Gygax et al.), and U.S. Patent Publication No. 20090320559 (Lemieuvre et al.), the contents of which are incorporated herein by reference. A preferred suitable method is described in PCT Application No. PCT / EP2022 / 052718 filed on February 4, 2022, the contents of which are incorporated herein by reference.

[0590] The fragrance composition of the present disclosure can be prepared according to any method known to those of ordinary skill in the art. Those of ordinary skill are fully capable of designing the best formula to achieve the desired effect by applying standard knowledge and concepts known to those of ordinary skill and utilizing conventional optimization methods to mix the above components to obtain the desired fragrance composition.

[0591] In a second aspect, the present disclosure relates to a perfumed consumer product comprising the fragrance composition described herein.

[0592] The form of the perfumed consumer product is not particularly limited. In one embodiment, the perfumed consumer product is a perfume, a fabric care product, a body care product, a cosmetic, a skin care product, an air care product or a home care product.

[0593] In another embodiment, the perfumed consumer product is a fine perfume, a splash perfume, an eau de parfum, or a fragrance. perfum), cologne, shaving lotion or aftershave, liquid or solid or single-dose detergent, fabric softener, solid or liquid fabric fragrance enhancer, fabric refresher, ironing water, paper, bleach, carpet cleaner, curtain care products, shampoo, leave-in or rinse-out hair conditioner (conditioner), dye preparations, dye care products, hair styling products, dental care products, disinfectants, intimate care products, hair spray (hair spray), vanishing cream, body deodorant (deodorant) or antiperspirant, hair remover, tanning product or sunscreen product, nail care product, skin cleanser, makeup, soap, shower or bath mousse, bath oil or shower gel, or foot / hand care product, hygiene products, air freshener, "ready-to-use" powder air freshener, mildew remover, furniture care products, wipes, dishwashing detergent or hard surface cleaner, leather care product, or car care product.

[0594] In one embodiment, the perfumed consumer product comprises the fragrance composition in an amount ranging from 1% to 95%, typically from 2% to 80%, more typically from 3% to 70% by weight relative to the total weight of the perfumed consumer product.

[0595] In one embodiment, the perfumed consumer product comprises the fragrance composition in an amount of 1% to 30%, typically 2% to 20%, more typically 3% to 10% by weight relative to the total weight of the perfumed consumer product.

[0596] In another embodiment, the at least two Group A ingredients are present in an amount of 0.01% to 95% by weight, typically 0.02% to 50%, more typically 0.03% to 20% by weight relative to the total weight of the perfumed consumer product.

[0597] In one embodiment, the at least two Group A ingredients are present in an amount of 0.1% to 15% by weight, typically 0.2% to 10%, more typically 0.3% to 5% by weight relative to the total weight of the perfumed consumer product.

[0598] In one embodiment, the at least two Group B components are present in an amount of 0.01% to 95% by weight, typically 0.02% to 50%, more typically 0.03% to 20% by weight relative to the total weight of the perfumed consumer product.

[0599] In one embodiment, the at least two Group B ingredients are present in an amount of 0.1% to 15% by weight, typically 0.2% to 10%, more typically 0.3% to 5% by weight relative to the total weight of the perfumed consumer product.

[0600] In a third aspect, the present disclosure relates to the use of a fragrance composition or a perfumed consumer product as described herein for providing a long-lasting fragrance trace.

[0601] The compositions, products and uses according to the present disclosure are further illustrated by the following non-limiting examples.

[0602] Example 1. The scent trace performance of the floral fragrance composition of the present invention

[0603] A panel of 10 experts evaluated two fragrance compositions, one inventive composition ("FLORTRAIL High") and one comparative composition ("FLORTRAIL Low"). These compositions are summarized in Tables 1 and 2 below. Amounts are expressed as weight percent and volatility is designated as follows - I: volatility > 1000 μg / L; II: volatility from 1000 μg / L to 100 μg / L; III: volatility from 100 μg / L to 10 μg / L; IV: volatility from 10 μg / L to 0.001 μg / L.

[0604] Table 1. FLORTRAIL Low

[0605]

[0606] Table 2. FLORTRAIL High

[0607]

[0608] The team evaluated the performance of fragrance traces at different distances (1m, 2m and 3m). The device described in PCT application number PCT / EP2022 / 052718 filed on February 4, 2022 was used to evaluate the fragrance traces at different times and distances from a limited source. The results are shown in Figure 1 and Figure 2 shown. Figure 1 Shown is the scent intensity of each composition evaluated at 1 meter, 2 meters and 3 meters after 30 minutes of drydown. Figure 2 The scent intensity of each composition evaluated at 1 meter, 2 meters and 3 meters after 4 hours of evaporation is shown.

[0609] like Figure 1 and Figure 2As shown, at 1 meter, 2 meters and 3 meters, after 30 minutes and 4 hours of volatilization, the scent intensity of FLORTRAIL High according to the present disclosure is higher than that of FLORTRAIL Low.

[0610] Example 2. The scent trace performance of the fruit-scented composition of the present invention

[0611] Two fragrance compositions, one inventive composition ("FRUITYTRAIL High") and one comparative composition ("FRUITYTRAIL Low"), were evaluated according to the method described in Example 1. These compositions are summarized in Tables 3 and 4 below. Amounts are expressed as weight percent and volatility is designated as follows - I: volatility > 1000 μg / L; II: volatility from 1000 μg / L to 100 μg / L; III: volatility from 100 μg / L to 10 μg / L; IV: volatility from 10 μg / L to 0.001 μg / L.

[0612] Table 3. FRUITYTRAIL Low

[0613]

[0614] Table 4. FRUITYTRAIL High

[0615]

[0616] The team evaluated the performance of fragrance traces at different distances (1m, 2m and 3m). The device described in PCT application number PCT / EP2022 / 052718 filed on February 4, 2022 was used to evaluate the fragrance traces at different times and distances from a limited source. The results are shown in Figure 3 and Figure 4 shown. Figure 3 Shown is the scent intensity of each composition evaluated at 1 meter and 3 meters after 30 minutes of evaporation. Figure 4 Shown is the scent intensity of each composition evaluated at 1 meter and 3 meters after 4 hours of evaporation.

[0617] like Figure 3 and Figure 4 As shown, at 1 meter and 3 meters, after 30 minutes and 4 hours of evaporation, the scent intensity of "FRUITYTRAIL High" prepared according to the present disclosure is higher than the scent intensity of the comparative "FRUITYTRAIL Low" formulation.

[0618] Example 3. The fragrance performance of the composition of the present invention relative to the commercial product

[0619] The product of the present invention ("Product A") consists of a floral base composition and a fragrance composition designed to produce a high intensity scent impression at various concentrations when added to the floral base. The ingredients of the floral base are summarized in Table 5 below. The ingredients of the fragrance composition are summarized in Table 6 below. Amounts are expressed as weight percent, and volatility is specified as follows - I: volatility > 1000 μg / L; II: volatility is 1000 μg / L to 100 μg / L; III: volatility is 100 μg / L to 10 μg / L; IV: volatility is 10 μg / L to 0.001 μg / L.

[0620] Table 5. Floral scent substrates

[0621]

[0622] Table 6. Fragrance composition

[0623]

[0624] Product A was then produced by adding 6 parts of the fragrance composition to 94 parts of the floral base. The resulting product contained 4.50% of the Volatile III Group A component, 1.00% of the Volatile IV Group A component, and 0.05% of the Volatile IV Group B component.

[0625] A panel of 11 respondents evaluated Product A and the commercial product ISSEY MIYAKE's EAU D'ISSEY. The fragrance EAU D'ISSEY was used as a benchmark for floral fragrances with above-average scent performance. The apparatus described in PCT application number PCT / EP2022 / 052718 was used to reproduce the scent conditions at 1 and 3 m distances at 2 hours. The results are summarized in Figure 5 middle. Figure 5 The intensity of the scent of the floral base, product A and EAU D'ISSEY at 1 meter and 3 meters after 2 hours of volatilization is shown.

[0626] The disclosed subject matter has been described with reference to specific details of particular embodiments. Unless such details are included in the appended claims, such details should not be construed as limitations on the scope of the disclosed subject matter.

[0627] Therefore, the exemplary embodiments described herein are well suited for achieving the objects and advantages described and those inherent therein. The specific embodiments disclosed above are illustrative only, as the exemplary embodiments described herein may be modified and practiced in different but equivalent manners, which will be apparent to those of ordinary skill in the art having the benefit of the teachings herein. In addition, the details of construction or design shown herein are not subject to any limitations except as described in the following claims. Therefore, it is apparent that the specific illustrative embodiments disclosed above may be changed, combined or modified, and all such variations are considered to be within the scope and spirit of the exemplary embodiments described herein. The exemplary embodiments described herein, which are illustratively disclosed herein, may be appropriately practiced in the absence of any elements not specifically disclosed herein and / or any optional elements disclosed herein.

Claims

1. A fragrance composition comprising at least 4%, typically at least 5%, more typically at least 6% by weight of at least two Group A components relative to the total weight of the composition, wherein the Group A components are selected from the group consisting of: (3aRS,5aRS,8aRS,8bSR)-2,2,6,6,7,8,8-heptamethyldecahydro-2H-indeno[4,5-b]furan, 4-Methoxybenzaldehyde, (+-)-1-(5-propyl-1,3-benzodioxol-2-yl) ketene, 3-(4-tert-Butylphenyl)propanal, 3-Butylidene-1-benzo[C]furanone, 7-methyl-2H-1,5-benzodioxepin-3(4H)-one, 5-isopropyl-2-methylphenol, 7-isopropyl-2H,4H-1,5-benzodioxepin-3-one, 4,8-cyclododecadien-1-one, (E)-3-phenyl-2-acrylonitrile, 3-Methyl-5-phenyl-2-pentenenitrile, (3S,3aR,5R,8S,8aS)-5-isopropenyl-3,8-dimethyloctahydro-3a(1H)-azulenol, Isopropenyl-1,4-dimethyldecahydro-4-azulenol, (1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane-3-ol, (1R,3R,6S,7S,8S)-3-ethoxy-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane, (+-)-6-methyl-7-oxa-1-thia-4-azaspiro[4.4]nonane, 4-Methylphenyl 3-methylbutyrate, (2E)-1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-butene-1-one, (+-)-(2E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one, (2E)-2-Dodecenal, (+-)-4-Methylene-2-phenyltetrahydro-2H-pyran, (+-)-4-methyl-6-phenyl-3,6-dihydro-2H-pyran, (+-)-4-methyl-2-phenyl-3,6-dihydro-2H-pyran, (E)-3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, 2,3-Epoxy-3-phenylbutyric acid ethyl ester, 2-ethyl-3-hydroxy-4(4H)-pyrone, 2-Methoxy-4-(2-propen-1-yl)phenol, 4-allyl-2-methoxyphenyl acetate, 2-methyl-4-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-1-ol, (+-)-5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone, (+-)-2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone, 4-methylphenoxy)acetaldehyde, 2-methoxy-4-[(1E)-1-propen-1-yl]phenol, 8-Isopropylquinoline, 6-Isopropylquinoline, 3,7-Dimethyl-6-octen-1-ol, 3,7-Dimethyl-7-octen-1-ol, (+-)-2-methyl-3-[4-(2-methyl-2-propyl)phenyl]propanal, (+-)-2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxane, 3,12-tridecadienenitrile, 2-aminobenzoic acid methyl ester, 2,6-Dimethoxyphenol, 3,6-Dimethylhexahydro-1-benzofuran-2(3H)-one, 1-(5,5-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one, (+-)-1-(5-ethyl-5-methyl-1-cyclohexen-1-yl)-4-penten-1-one, 1-(3-methyl-1-benzofuran-2-yl)ethanone, 5-Nonanolactone, (+-)-4-nonalactone, Perhydro-2-benzopyrone, 1-(2-aminophenyl)-1-ethanone, (-)-(1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane-3-ol, (E)-2-ethoxy-5-(1-propenyl)phenol, 3-Methylindole, 1-Oxaspiro[4.5]decan-2-one, (4Z)-4-Dodecenal, 1,5,9-Trimethyl-4,8-decadienyl acetate, 3-Methyl-4-octanolactone, 3-Propylphenol, 2-Methoxynaphthalene; (+-)-2-[4-(2-hydroxy-2-methylpropyl)phenyl]propanal, 3-(3-(2-hydroxy-2-methylpropyl)phenyl)propanal, 3-[4-(2-Hydroxy-2-methylpropyl)phenyl]propanal, 4-(4-methoxyphenyl)-2-butanone, 2-(3-phenylpropyl)pyridine, (-)-(2E)-2-ethyl-4-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-2-buten-1-ol, (+-)-6-pentyltetrahydro-2H-pyran-2-one, 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal, 3-(1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)propanal, 3-(1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal, (E)-2-methoxy-4-(1-propenyl)phenyl acetate, (1'S,3'R)-{1-methyl-2-[(1',2',2'-trimethylbicyclo[3.1.0]hex-3'-yl)methyl]cyclopropyl}methanol, (+-)-(2,5-dimethyl-2,3-dihydro-1H-inden-2-yl)methanol; (+-)-3-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde, (+-)-4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde, 2,4-dihydroxy-3,6-dimethylbenzoic acid methyl ester, 4-(4-Hydroxyphenyl)-2-butanone, (+)-(1R,7R)-10,10-dimethyl-tricyclo[7.1.1.0(2,7)]undec-2-en-4-one, (+-)-5-heptyldihydro-2(3H)-furanone, 4-Hydroxy-3-methoxybenzaldehyde, (-)-(3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan, (-)-(1R,3S,7R,8R,10S,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.0(1,10).0(3,7)]tetradecane, and any combination thereof; And wherein the volatility of each of the at least two Group A components is less than 100 μg / L, typically 100 μg / L to 10 μg / L, or 10 μg / L to 0.001 μg / L.

2. The fragrance composition according to claim 1, wherein the at least two Group A components are present in an amount of 4% to 95% by weight relative to the total weight of the composition, typically 5% to 80%, more typically 6% to 70%.

3. The fragrance composition according to claim 1 or 2, further comprising at least 1%, typically at least 3%, more typically at least 4% by weight of at least two Group B components relative to the total weight of the composition, wherein the Group B components are selected from the group consisting of: 1-(4-methoxyphenyl)-1-ethanone, (+-)-8α,8A-Epoxy-perhydro-2β,5,5-trimethyl-2-trans-naphthol, (+-)-4A,8A-Epoxy-perhydro-2,5,5-trimethyl-2-naphthol, (+-)-4-(C-2,3-epoxy-2,6,6-trimethyl-R-1-cyclohexyl)-2-butanone, 4-Methoxybenzyl acetate, 4-Methoxy-1-benzyl alcohol, (E)-2-Methyl-2-butenoic acid benzyl ester, (+-)-1,1,2,3,3-pentamethyl-1,2,3,5,6,7-hexahydro-4H-inden-4-one, Cedre-8-ene, 1-(Cedre-8-en-9-yl)vinyl ketone, (2E)-3-phenyl-2-propen-1-ol, (E)-3-phenyl-2-propenal, (E)-3-phenyl-2-propenyl acetate, 3-methyl-2-[(2Z)-2-penten-1-yl]-2-cyclopenten-1-one, 3-Hydroxy-2-methyl-4H-pyran-4-one, Allyl (cyclohexyloxy)acetate, 2-Methoxy-4-propylphenol, 4-Methyl-2-phenyltetrahydro-2H-pyran, (2E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one, (E)-3-phenyl-2-propenoic acid ethyl ester, 3-(4-ethylphenyl)-2,2-dimethylpropanal, 3-(2-ethylphenyl)-2,2-dimethylpropanal, (+-)-3-(3-isopropyl-1-phenyl)butyraldehyde, (+-)-(E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one, (+-)-(E)-1-(2,2-dimethyl-6-methylene-1-cyclohexyl)-1-penten-3-one, (E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1-penten-3-one, (E)-3,7-dimethyl-2,6-octadien-1-ol, Benzo[d][1,3]dioxole-5-carboxaldehyde, (+-)-(3E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (+-)-(1E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one, (+-)-(E)-trans-α-irone, (+-)-(E)-cis-α-irone, (+-)-(E)-β-irone, (+-)-(3E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (+-)-(1E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one, 3,7-Dimethyl-2,6-nonadienenitrile, 3,7-Dimethyl-3,6-nonadienenitrile, 10-Methyl-α-ionone, 10-Methyl-β-ionone, 10-Methyl-γ-ionone, (1E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1-penten-3-one, (+)-3,3-dimethyl-5-[(1S)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol, (+-)-6-propyltetrahydro-2H-pyran-2-one, (1RS,4aSR,8RS,8aSR)-2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a-octahydro-1-naphthol, (3Z)-3-hexen-1-yl hexanoate, 2,4,6,8-Tetramethylnonyl acetate, (-)-3,3-dimethyl-5-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol, (2RS,4aRS,8aSR)-5,5,8a-trimethyldecahydro-2-naphthyl acetate, (2S,5R)-5-methyl-2-(2-propyl)cyclohexanone oxime, 2,6,10,10-Tetramethyl-1-oxaspiro[4.5]decan-6-ol, (4Z)-4-Dodecenenitrile, Dodecanonitrile, Thymol, Propionic acid tricyclo[5.2.1.0(2,6)]dec-3-en-8-yl ester, Propionic acid tricyclo[5.2.1.0(2,6)]dec-4-en-8-yl ester, 2-tert-Butyl-1,4-dimethoxybenzene, (+-)-(3E)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (3E)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one, 4-Methyl-6-phenyl-2-hexanol, 9-Hydroxy-5,9-dimethyl-4-decenal; 7-propyl-2H,4H-1,5-benzodioxepin-3-one, Allyl phenoxyacetate, (3aRS,5aSR,9aSR,9bRS)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan, (3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan, (3aRS,5aSR,9aSR,9bRS)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan, (3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan, (3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan, (+-)-2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol, (E)-3-phenyl-2-propenyl propionate, [3-oxo-2-pentylcyclopentyl]acetic acid methyl ester, 2-Benzopyrone, (+-)-4-Decalactone, (+-)-5-octyldihydro-2(3H)-furanone, (+-)-6-Heptyltetrahydro-2H-pyran-2-one, (+-)-3-(1,3-benzodioxol-5-yl)-2-methylpropanal, 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal, 3-(1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal, 2-Methylpropionic acid 4-formyl-2-methoxyphenyl ester, (+-)-8-sec-butylquinoline, (+-)-6-sec-butylquinoline, (+-)-6-[(2Z)-2-penten-1-yl]tetrahydro-2H-pyran-2-one, 2-Ethoxy-4-(methoxymethyl)phenol, 1-(2-Naphthyl)ethylene ketone, (4E)-4-methyl-5-(4-methylphenyl)-4-pentenal, 2-{2-[(1R)-4-methyl-3-cyclohexen-1-yl]propyl}cyclopentanone, (+)-(4R,4aS,6R)-4,4a-dimethyl-6-(1-propen-2-yl)-4,4a,5,6,7,8-hexahydro-2(3H)-naphthalenone, 1-[2,2,6-trimethylcyclohexyl]-3-hexanol, 2-Tridecenenitrile, 3-Tridecenenitrile, 4-Methylphenyl phenylacetate, (+-)-3-methyl-5-phenyl-1-pentanol, (+-)-2,3,3-Trimethyl-1-indanone, 2-(4-methyl-1,3-thiazol-5-yl)-1-ethanol, 7-(2-methyl-2-n-propyl)-2H-1,5-benzodioxepin-3(4H)-one, (E)-2-Tridecene aldehyde, 6-Hexyltetrahydro-2H-pyran-2-one, 2-Methoxy-4-methylphenyl methyl carbonate, (+)-(1S,2S,3S,5R)-2,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,1'-cyclohexane]-2'-en-4'-one, (1S,4S,9S,10R,13R)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane, (1R,4S,9S,10R,13S)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane, and any combination thereof; And wherein the volatility of each of the at least two Group B components is less than 100 μg / L, typically 100 μg / L to 10 μg / L, or 10 μg / L to 0.001 μg / L.

4. The fragrance composition according to claim 3, wherein the at least two Group B components are present in an amount of 1% to 95% by weight, typically 3% to 80%, more typically 4% to 70% by weight relative to the total weight of the composition. 5 . The fragrance composition according to claim 3 , wherein the volatility of at least one of the at least two Group A components and / or at least one of the at least two Group B components is from 10 μg / L to 0.001 μg / L.

6. The fragrance composition according to any one of claims 3 to 5, wherein at least one of the at least two Group A components and / or at least one of the at least two Group B components has a volatility of 100 μg / L to 10 μg / L.

7. The fragrance composition according to any one of claims 1 to 6, further comprising at least 0.1%, typically at least 2%, more typically at least 4% by weight relative to the total weight of the composition of at least two ingredients selected from A' component, B' component or a combination thereof, each of the at least two ingredients having a volatility range of 1000 μg / L to 100 μg / L, wherein the A' component is selected from the group consisting of: 1-(Pyrazinyl)-1-ethanone, (+-)-2-Methylundecanal, 10-Undecenal, 9-Undecenal, Allyl (3-methylbutoxy)acetate, (2-Methylbutoxy)acetic acid (+-)-allyl ester, (-)-(5R)-5-isopropenyl-2-methyl-2-cyclohexen-1-one, (+-)-3-Mercaptohexyl acetate, (Z)-4-Decenal, (2E)-1-[(1RS,2SR)-2,6,6-trimethyl-3-cyclohexen-1-yl]-2-buten-1-one, 4-Ethyl-2-methoxyphenol, 4,6,6-Trimethyl-1,3-cyclohexadiene-1-carboxylic acid ethyl ester, (+-)-4-Hydroxy-2,5-dimethyl-3(2H)-furanone, (3E,5Z)-1,3,5-Undecatriene, (+-)-Perhydro-4α,8Aβ-dimethyl-4A-naphthol, 2-Methoxyphenol, 8-isopropyl-6-methyl-bicyclo[2.2.2]oct-5-ene-2-carbaldehyde, 2-Hexyl-2-cyclopenten-1-one, 2-Methoxy-3-(4-methylpentyl)pyrazine, 2-Octynoic acid methyl ester, 1-(4-Methylphenyl) ketene, (+-)-2-Methyldecanal, (2E,6Z)-1,1-diethoxy-2,6-nonadiene, (Z)-2-nonenal, 2-Hydroxy-3-methyl-2-cyclopenten-1-one, γ-Octyl lactone, 2,6,6-Trimethyl-2-cyclohexene-1,4-dione, 4-Methylphenol, 4-Methylphenyl acetate, 4-Methylphenyl isobutyrate, (+-)-cis-tetrahydromethyl-4-methylene-6-phenyl-2H-pyran, (+-)-cis-3,6-dihydro-4,6-dimethyl-2-phenyl-2H-pyran, (+-)-cis-3,6-dihydro-2,4-dimethyl-6-phenyl-2H-pyran, (2E,6Z)-2,6-nonadienal, (2E,6Z)-2,6-nonadien-1-ol, 3-phenylpropanal, 3-(6,6-dimethyl-bicyclo[3.1.1]hept-2-en-2-yl)propanal, (+-)-2,4-dimethyl-4-phenyltetrahydrofuran, 2,6,6-Trimethyl-1,3-cyclohexadiene-1-carbaldehyde, (1R,4R)-8-Mercapto-3-menthone, (4E)-4-Decenal, 2-Ethoxy-4-methylphenol, (+-)-(4Z)-4-cycloocten-1-yl methyl carbonate, 2,6-nonadienenitrile, (+-)-2-(4-methyl-3-cyclohexen-1-yl)-2-propanethiol, and any combination thereof; and the B' component is selected from the group consisting of: decanal, Dodecanal, 1-Methoxy-4-[(1E)-1-propen-1-yl]benzene, 4-phenyl-2-butanone, (+)-(5S)-5-isopropenyl-2-methyl-2-cyclohexen-1-one, (+)-(R)-3,7-dimethyl-6-octenal, (+-)-3,7-dimethyl-6-octenal, 5,9-Dimethyl-4-decenal, 2-Methoxy-4-methylphenol, 3-Hexenoic acid cyclopropyl methyl ester, (+-)-2-Pentylcyclopentanone, (+-)-2,6-dimethyl-7-octen-2-ol, 3,7-Dimethyl-1,6-nonadien-3-ol, Ethyl phenylacetate, 2-Methyl-1,3-dioxolane-2-acetic acid ethyl ester, 3-(2,2-dimethylpropyl)pyridine, tricyclo[5.2.1.0.(2,6)]decane-2-carboxylic acid ethyl ester, formic acid (+-)-3,7-dimethyl-6-octen-1-yl ester, formic acid (2E)-3,7-dimethyl-2,6-octadien-1-yl ester, 3,7-dimethyl-2,6-octadienenitrile, (+-)-4-Heptanolide, 1-Phenylvinyl acetate, (8E)-8-Undecenal, 10-Undecenal, (9E)-9-Undecenal, (+)-3-[(1R)-4-methyl-3-cyclohexen-1-yl]butanal, (+-)-3,7-dimethyl-1,6-octadien-3-ol, methyl phenylacetate, (+-)-2-Methyldecanenitrile, 2-Phenylethyl acetate, 2-phenylethanol, 2-Acetyl-4-methyl-4-pentenoic acid (+-)-ethyl ester, (Z)-3-nonenyl acetate, (Z)-6-nonenyl acetate, (Z,Z)-3,6-nonadienyl acetate, (2E,6Z)-2,6-nonadienyl acetate, 3-(4,4-dimethyl-1-cyclohexen-1-yl)propanal, (+-)-3-phenylbutyraldehyde, 2-Methyl-3-hexanone oxime, 1,3-Undecadien-5-yne, (+-)-4-methoxy-2,5-dimethyl-3(2H)-furanone, (+-)-6-methoxy-2,6-dimethylheptanal, and any combination thereof.

8. The fragrance composition according to any one of claims 1 to 7, wherein at least one of the at least two Group A components is selected from the group consisting of: (+-)-2-[4-(2-hydroxy-2-methylpropyl)phenyl]propanal, 3-(3-(2-hydroxy-2-methylpropyl)phenyl)propanal, 3-[4-(2-Hydroxy-2-methylpropyl)phenyl]propanal, (+-)-1-(5-propyl-1,3-benzodioxol-2-yl) ketene, (3S,3aR,5R,8S,8aS)-5-isopropenyl-3,8-dimethyloctahydro-3a(1H)-azulenol, 7-isopropenyl-1,4-dimethyldecahydro-4-azulenol, (1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecan-3-ol, (1R,3R,6S,7S,8S)-3-ethoxy-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecane, (+-)-6-methyl-7-oxa-1-thia-4-azaspiro[4.4]nonane, (2E)-2-Dodecenal, (+-)-4-Methylene-2-phenyltetrahydro-2H-pyran, (+-)-4-methyl-6-phenyl-3,6-dihydro-2H-pyran, (+-)-4-methyl-2-phenyl-3,6-dihydro-2H-pyran, 3,6-Dimethylhexahydro-1-benzofuran-2(3H)-one, (+-)-1-(5-ethyl-5-methyl-1-cyclohexen-1-yl)-4-penten-1-one, (-)-(1R,3R,6S,7S,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.0~3,8~]undecan-3-ol, 1-oxaspiro[4.5]decan-2-one, (4Z)-4-Dodecenal, 3-propylphenol, and any combination thereof.

9. The fragrance composition according to any one of claims 4 to 6, wherein at least one of the at least two Group B components is selected from the group consisting of: 7-propyl-2H,4H-1,5-benzodioxepin-3-one, (4E)-4-methyl-5-(4-methylphenyl)-4-pentenal, 7-(2-methyl-2-n-propyl)-2H-1,5-benzodioxepin-3(4H)-one, 2-Methoxy-4-methylphenyl methyl carbonate, (+)-(1S,2S,3S,5R)-2,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,1'-cyclohexane]-2'-en-4'-one, (1S,4S,9S,10R,13R)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane, (1R,4S,9S,10R,13S)-5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.0~1,10~.0~4,9~]hexadecane, (+)-3,3-dimethyl-5-[(1S)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol, (1RS,4aSR,8RS,8aSR)-2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a-octahydro-1-naphthol, (2RS,4aRS,8aSR)-5,5,8a-trimethyldecahydro-2-naphthyl acetate, (2S,5R)-5-methyl-2-(2-propyl)cyclohexanone oxime, 2,6,10,10-Tetramethyl-1-oxaspiro[4.5]decan-6-ol, 4-methyl-6-phenyl-2-hexanol, and any combination thereof.

10. The fragrance composition according to any one of claims 1 to 9, further comprising at least 0.1%, typically at least 2%, more typically at least 4% by weight relative to the total weight of the composition, of at least two ingredients selected from A" components, B" components or a combination thereof, each of the at least two ingredients having a volatility greater than or equal to 1000 μg / L, wherein the A" components are selected from the group consisting of: 1-(2-Pyridyl)-1-ethanone, 2,3-Pentanedione, 1-(1,3-thiazol-2-yl)-1-ethanone, Heptanal, Octanal, (+-)-2-Methylvalerate Ethyl ester, 2-Furanmethylthiol, (+-)-1-octen-3-ol, (Z)-6-nonenal, 4-Mercapto-4-methyl-2-pentanone, (1RS,6RS)-3,6-dimethyl-3-cyclohexene-1-carbaldehyde, 4,6-Dimethyl-3-cyclohexene-1-carbaldehyde, 2-Methylbutyric acid (+-)-ethyl ester, Ethyl benzoate, Ethyl butyrate, Ethylhexanoate, 3-Ethyl-2,5-dimethylpyrazine, 2-Ethyl-3,5-dimethylpyrazine, Ethyl isobutyrate, 2-Ethyl-3-methylpyrazine, 5-methyl-2-hepten-4-one, 2-Isopropyl-3-methoxypyrazine, (+-)-2,6-dimethyl-5-heptenal, 2-Methoxy-3-methylpyrazine, 2-Methoxy-6-methylpyrazine, 2-isopropyl-4-methylthiazole, Diallyl disulfide, (1R,5R)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]oct-3-ene, (1R,4R,5R)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane, 1-decene-4-yne, Butylpyrazole, 2-Methoxy-3-(1-methylpropyl)pyrazine, 2,2-Dimethyl-6-methylidenecyclohexanecarboxylic acid (+-)-methyl ester, (+-)-2-ethyl-4,4-dimethyl-1,3-oxathiinane, (+-)-1-methoxy-3-hexanethiol, 2,3,5-Trimethylpyrazine, Trimethylamine, 3-Methyl-2-oxopentanoic acid (+-)-ethyl ester, 2,4-dimethyl-3-cyclohexene-1-carbaldehyde, and any combination thereof; and the B" component is selected from the group consisting of: Acetophenone, (+-)-3-Hydroxy-2-butanone, Hexanal, Nonanal, 3-Methylbutyl propionate, 2-Methylbutyl propionate, (2E)-2-methyl-2-hexenoic acid methyl ester, 1,1-diethoxy-3,7-dimethyl-2,6-octadiene, Cyclohexyl acetate, Dibutyl sulfide, 1,3,3-Trimethyl-2-oxabicyclo[2.2.2]octane, (+)-(1R,2R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol, 2-phenylpropanal, 3,5,6-Trimethyl-3-cyclohexene-1-carbaldehyde, 2,4,6-Trimethyl-3-cyclohexene-1-carbaldehyde, Methyl 3-(methylthio)propionate, 1-Methoxy-4-methylbenzene, 7-Methyl-3-methylene-1,6-octadiene, (3Z)-1-[2-buten-1-yloxy]-3-hexene, 2-Methyl-4-propyl-1,3-oxathiinane, (2-methoxyethyl)benzene, (Z)-3-hexenyl acetate, (Z)-3-Hexenyl formate, 4-methyl-2-(2-methyl-1-propen-1-yl)tetrahydro-2H-pyran, 2,2-dimethylpropanoic acid (-)-(2S)-1-oxo-1-(2-n-propoxy)-2-n-propyl ester, (2E)-2-octen-4-one, (2E)-2-hexenal, and any combination thereof.

11. The fragrance composition according to any one of claims 1 to 10, further comprising a fixative.

12. A perfumed consumer product comprising a fragrance composition according to any one of claims 1 to 11.

13. The fragranced consumer product according to claim 12, wherein the fragranced consumer product is a perfume, a fabric care product, a body care product, a cosmetic, a skin care product, an air care product or a home care product.

14. The perfumed consumer product according to claim 12 or 13, wherein the perfumed consumer product is a fine perfume, a rub-on perfume, an eau de parfum, a cologne, a shaving lotion or aftershave, a liquid or solid or single-dose detergent, a fabric softener, a solid or liquid fabric fragrance enhancer, a fabric refresher, an ironing water, paper, a bleach, a carpet cleaner, a curtain care product, a shampoo, a leave-in or rinse-off hair conditioner, a dyeing preparation, a color care product, a hair styling product, a dental care product, a disinfectant, a private care product, a hair spray, a vanishing cream, a deodorant or antiperspirant, a depilatory, a tanning product or a sunscreen product, a nail product, a skin cleanser, a make-up product, a soap, a mousse for the shower or bath, a bath oil or a shower gel, a foot / hand care product, a hygiene product, an air freshener, a "ready-to-use" powder air freshener, a mildew remover, a furniture care product, a wipe, a dishwashing detergent or a hard surface detergent, a leather care product, or a car care product.

15. Use of a fragrance composition according to any one of claims 1 to 11 or a perfumed consumer product according to claim 13 or 14 for providing a long-lasting fragrance trace.

Images